Literature DB >> 20117376

The hypertensive heart. An integrated understanding informed by imaging.

Subha V Raman1.   

Abstract

Clinical sequelae of hypertension include heart failure, arrhythmias, and ischemic events, especially myocardial infarction and stroke. Recognizing the hypertensive heart has diagnostic as well as prognostic implications. Current imaging techniques offer noninvasive approaches to detecting myocardial fibrosis, ischemia, hypertrophy, and disordered metabolism that form the substrate for hypertensive heart disease. In addition, recognition of aortopathy and atrial myopathy as contributors to myocardial disease warrant incorporation of aortic and atrial functional measurements into a comprehensive understanding of the hypertensive heart.

Entities:  

Mesh:

Year:  2010        PMID: 20117376      PMCID: PMC2853718          DOI: 10.1016/j.jacc.2009.07.059

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  39 in total

1.  Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease.

Authors:  C G Brilla; R C Funck; H Rupp
Journal:  Circulation       Date:  2000-09-19       Impact factor: 29.690

2.  Cardiac cycle-dependent changes in aortic area and distensibility are reduced in older patients with isolated diastolic heart failure and correlate with exercise intolerance.

Authors:  W G Hundley; D W Kitzman; T M Morgan; C A Hamilton; S N Darty; K P Stewart; D M Herrington; K M Link; W C Little
Journal:  J Am Coll Cardiol       Date:  2001-09       Impact factor: 24.094

3.  In-vivo intracellular pH at rest and during exercise in patients with essential hypertension.

Authors:  T K Khong; D J McIntyre; G A Sagnella; N D Markandu; M A Miller; E H Baker; J R Griffiths; G A MacGregor
Journal:  J Hypertens       Date:  2001-09       Impact factor: 4.844

4.  Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension.

Authors:  G Schillaci; P Verdecchia; C Porcellati; O Cuccurullo; C Cosco; F Perticone
Journal:  Hypertension       Date:  2000-02       Impact factor: 10.190

5.  Wall stress and patterns of hypertrophy in the human left ventricle.

Authors:  W Grossman; D Jones; L P McLaurin
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

6.  Repolarization abnormalities of left ventricular hypertrophy. Clinical, echocardiographic and hemodynamic correlates.

Authors:  R B Devereux; N Reichek
Journal:  J Electrocardiol       Date:  1982-01       Impact factor: 1.438

7.  Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial.

Authors:  Richard B Devereux; Björn Dahlöf; Eva Gerdts; Kurt Boman; Markku S Nieminen; Vasilios Papademetriou; Jens Rokkedal; Katherine E Harris; Jonathan M Edelman; Kristian Wachtell
Journal:  Circulation       Date:  2004-08-23       Impact factor: 29.690

8.  Influence of myocardial fibrosis on left ventricular diastolic function: noninvasive assessment by cardiac magnetic resonance and echo.

Authors:  Antonella Moreo; Giuseppe Ambrosio; Benedetta De Chiara; Min Pu; Tam Tran; Francesco Mauri; Subha V Raman
Journal:  Circ Cardiovasc Imaging       Date:  2009-09-03       Impact factor: 7.792

9.  Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy.

Authors:  J M McLenachan; E Henderson; K I Morris; H J Dargie
Journal:  N Engl J Med       Date:  1987-09-24       Impact factor: 91.245

10.  Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy.

Authors:  Frank Grothues; Gillian C Smith; James C C Moon; Nicholas G Bellenger; Peter Collins; Helmut U Klein; Dudley J Pennell
Journal:  Am J Cardiol       Date:  2002-07-01       Impact factor: 2.778

View more
  22 in total

Review 1.  Clinical and prognostic value of hypertensive cardiac damage in the PAMELA Study.

Authors:  Cesare Cuspidi; Carla Sala; Anna Casati; Michele Bombelli; Guido Grassi; Giuseppe Mancia
Journal:  Hypertens Res       Date:  2016-11-17       Impact factor: 3.872

Review 2.  Etiopathogenesis of microvascular angina: caveats in our knowledge.

Authors:  S R Mittal
Journal:  Indian Heart J       Date:  2014-11-04

Review 3.  Is Left Ventricular Hypertrophy a Valid Therapeutic Target?

Authors:  Jeremy Earl Brooks; Elsayed Z Soliman; Bharathi Upadhya
Journal:  Curr Hypertens Rep       Date:  2019-05-20       Impact factor: 5.369

4.  Left atrial enlargement and blood pressure variability in untreated hypertensive patients.

Authors:  Naoki Nakagawa; Naoyuki Hasebe
Journal:  Hypertens Res       Date:  2016-05-19       Impact factor: 3.872

5.  Significance of fragmented QRS complexes for identifying left ventricular hypertrophy in patients with hypertension.

Authors:  Baowei Zhang; Ya Zhen; Dongli Shen; Guohui Zhang
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-09-18       Impact factor: 1.468

Review 6.  Recent Advances in Imaging of Hypertensive Heart Disease.

Authors:  Christopher L Schumann; Nicholas R Jaeger; Christopher M Kramer
Journal:  Curr Hypertens Rep       Date:  2019-01-14       Impact factor: 5.369

Review 7.  MicroRNA signatures of resveratrol in the ischemic heart.

Authors:  Partha Mukhopadhyay; Pal Pacher; Dipak K Das
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

Review 8.  Hypertension as a risk factor for heart failure.

Authors:  Arun Kannan; Rajesh Janardhanan
Journal:  Curr Hypertens Rep       Date:  2014-07       Impact factor: 5.369

Review 9.  Imaging in hypertensive heart disease.

Authors:  Rajesh Janardhanan; Christopher M Kramer
Journal:  Expert Rev Cardiovasc Ther       Date:  2011-02

Review 10.  Myocardial remodeling in hypertension.

Authors:  W Nadruz
Journal:  J Hum Hypertens       Date:  2014-05-08       Impact factor: 3.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.